Amphastar Pharmaceuticals Inc
AMPH29.260USD
+0.630+2.20%
Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min
1.36BCap. mercado
12.41P/E TTM
Más Datos de Amphastar Pharmaceuticals Inc Compañía
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. The Company manufactures and sells over 25 products, such as BAQSIMI (glucagon) nasal powder 3mg, Primatene MIST, Glucagon for Injection Emergency Kit, Enoxaparin, Naloxone and Other Marketed Products, including Cortrosyn (cosyntropin for injection), Amphadase, Epinephrine injection, Lidocaine jelly, Lidocaine topical solution, Phytonadione injection, and others. The Company manufactures and sells two API products, Recombinant Human Insulin (RHI API) and porcine insulin API, for the injectable insulin market.
Información de Amphastar Pharmaceuticals Inc
Símbolo de cotizaciónAMPH
Nombre de la empresaAmphastar Pharmaceuticals Inc
Fecha de salida a bolsaJun 25, 2014
Director ejecutivoZhang (Yongfeng Yongfeng)
Número de empleados2028
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 25
Dirección11570 6th St
CiudadRANCHO CUCAMONGA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal91730
Teléfono19099809484
Sitio Webhttps://amphastar.com/
Símbolo de cotizaciónAMPH
Fecha de salida a bolsaJun 25, 2014
Director ejecutivoZhang (Yongfeng Yongfeng)
Ejecutivos de Amphastar Pharmaceuticals Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Rong Zhou
Mr. Rong Zhou
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
197.10K
--
Dr. Howard S. Lee, Ph.D.
Dr. Howard S. Lee, Ph.D.
Independent Director
Independent Director
148.90K
+4199.00%
Mr. Floyd F. Petersen
Mr. Floyd F. Petersen
Independent Director
Independent Director
68.29K
-4163.00%
Mr. William J. Peters
Mr. William J. Peters
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
55.44K
-273.00%
Mr. Richard K. Prins
Mr. Richard K. Prins
Lead Independent Director
Lead Independent Director
32.11K
--
Ms. Gayle Deflin
Ms. Gayle Deflin
Independent Director
Independent Director
7.84K
+5122.00%
Dr. Yongfeng (Jack) Zhang, Ph.D.
Dr. Yongfeng (Jack) Zhang, Ph.D.
President, Chief Executive Officer, Chief Scientific Officer, Director
President, Chief Executive Officer, Chief Scientific Officer, Director
--
--
Dr. Ziping (Mary) Luo, Ph.D.
Dr. Ziping (Mary) Luo, Ph.D.
Chairman of the Board, Chief Operating Officer, Chief Scientist
Chairman of the Board, Chief Operating Officer, Chief Scientist
--
--
Ms. Diane G. Gerst
Ms. Diane G. Gerst
Independent Director
Independent Director
--
--
Dr. Michael A. Zasloff, M.D., Ph.D.
Dr. Michael A. Zasloff, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Rong Zhou
Mr. Rong Zhou
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
197.10K
--
Dr. Howard S. Lee, Ph.D.
Dr. Howard S. Lee, Ph.D.
Independent Director
Independent Director
148.90K
+4199.00%
Mr. Floyd F. Petersen
Mr. Floyd F. Petersen
Independent Director
Independent Director
68.29K
-4163.00%
Mr. William J. Peters
Mr. William J. Peters
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
55.44K
-273.00%
Mr. Richard K. Prins
Mr. Richard K. Prins
Lead Independent Director
Lead Independent Director
32.11K
--
Ms. Gayle Deflin
Ms. Gayle Deflin
Independent Director
Independent Director
7.84K
+5122.00%
Desglose de ingresos
Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
180.28M
93.97%
France
9.68M
5.05%
China
1.88M
0.98%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.
Estadísticas de accionistas
Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Applied Physics & Chemistry Laboratories, Inc.
14.86%
BlackRock Institutional Trust Company, N.A.
10.75%
Zhang (Jack Yongfeng)
5.71%
The Vanguard Group, Inc.
5.63%
TD Asset Management Inc.
4.20%
Otro
58.85%
Accionistas
Accionistas
Proporción
Applied Physics & Chemistry Laboratories, Inc.
14.86%
BlackRock Institutional Trust Company, N.A.
10.75%
Zhang (Jack Yongfeng)
5.71%
The Vanguard Group, Inc.
5.63%
TD Asset Management Inc.
4.20%
Otro
58.85%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
40.25%
Investment Advisor/Hedge Fund
22.89%
Corporation
14.86%
Individual Investor
9.43%
Hedge Fund
6.46%
Research Firm
2.82%
Pension Fund
1.05%
Bank and Trust
0.31%
Family Office
0.28%
Otro
1.65%
Participación institucional
Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
586
33.97M
85.20%
+16.67K
2025Q3
603
33.96M
84.80%
+202.84K
2025Q2
607
33.74M
83.87%
-544.61K
2025Q1
597
34.53M
80.40%
-3.80M
2024Q4
593
35.69M
79.40%
-112.11K
2024Q3
575
35.68M
75.48%
+965.70K
2024Q2
565
34.64M
73.86%
+833.26K
2024Q1
548
33.97M
73.49%
-1.92M
2023Q4
531
33.91M
72.12%
+1.03M
2023Q3
499
32.97M
71.03%
+509.94K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Applied Physics & Chemistry Laboratories, Inc.
6.83M
14.86%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
4.94M
10.75%
-185.58K
-3.62%
Sep 30, 2025
Zhang (Jack Yongfeng)
2.62M
5.71%
+200.00K
+8.25%
Jun 13, 2025
The Vanguard Group, Inc.
2.61M
5.68%
-55.91K
-2.10%
Sep 30, 2025
TD Asset Management Inc.
1.93M
4.2%
-103.04K
-5.06%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.76M
3.82%
+128.78K
+7.92%
Sep 30, 2025
State Street Investment Management (US)
1.50M
3.27%
-75.49K
-4.79%
Sep 30, 2025
Fuller & Thaler Asset Management Inc.
1.35M
2.95%
+90.16K
+7.13%
Sep 30, 2025
Epoch Investment Partners, Inc.
1.13M
2.47%
-107.38K
-8.65%
Sep 30, 2025
Luo (Mary Z)
1.09M
2.37%
+69.40K
+6.79%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Invesco Pharmaceuticals ETF
2.25%
State Street SPDR S&P Pharmaceuticals ETF
1.47%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.38%
Invesco S&P SmallCap 600 GARP ETF
1.12%
Acquirers Small and Micro Deep Value ETF
0.87%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.77%
Invesco S&P SmallCap Health Care ETF
0.56%
First Trust Small Cap Value AlphaDEX Fund
0.5%
Distillate Small/Mid Cash Flow ETF
0.45%
VictoryShares Small Cap Free Cash Flow ETF
0.37%
Ver más
Invesco Pharmaceuticals ETF
Proporción2.25%
State Street SPDR S&P Pharmaceuticals ETF
Proporción1.47%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporción1.38%
Invesco S&P SmallCap 600 GARP ETF
Proporción1.12%
Acquirers Small and Micro Deep Value ETF
Proporción0.87%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proporción0.77%
Invesco S&P SmallCap Health Care ETF
Proporción0.56%
First Trust Small Cap Value AlphaDEX Fund
Proporción0.5%
Distillate Small/Mid Cash Flow ETF
Proporción0.45%
VictoryShares Small Cap Free Cash Flow ETF
Proporción0.37%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
